Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Media (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pharma Services company Open Orphan presenting at Hardman's November Forum

Welcome to the November Hardman & Co Investor Forum. Hardman had the usual four companies presenting, filmed by London South East on behalf of Hardman.

Open Orphan #ORPH was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.

Related ORPH.L Media

Open Orphan added bed capacity, announced new facilities and are targeting 50M revenues for 2022

What's Hot March 1st

Cathal Friel announces Open Orphan to spin out 4 non-core companies

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.